Dopamine receptor activation increases HIV entry into primary human macrophages.
Macrophages are the primary cell type infected with HIV in the central nervous system, and infection of these cells is a major component in the development of neuropathogenesis and HIV-associated neurocognitive disorders. Within the brains of drug abusers, macrophages are exposed to increased levels...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4182469?pdf=render |
| _version_ | 1818050076101050368 |
|---|---|
| author | Peter J Gaskill Hideaki H Yano Ganjam V Kalpana Jonathan A Javitch Joan W Berman |
| author_facet | Peter J Gaskill Hideaki H Yano Ganjam V Kalpana Jonathan A Javitch Joan W Berman |
| author_sort | Peter J Gaskill |
| collection | DOAJ |
| description | Macrophages are the primary cell type infected with HIV in the central nervous system, and infection of these cells is a major component in the development of neuropathogenesis and HIV-associated neurocognitive disorders. Within the brains of drug abusers, macrophages are exposed to increased levels of dopamine, a neurotransmitter that mediates the addictive and reinforcing effects of drugs of abuse such as cocaine and methamphetamine. In this study we examined the effects of dopamine on HIV entry into primary human macrophages. Exposure to dopamine during infection increased the entry of R5 tropic HIV into macrophages, irrespective of the concentration of the viral inoculum. The entry pathway affected was CCR5 dependent, as antagonizing CCR5 with the small molecule inhibitor TAK779 completely blocked entry. The effect was dose-dependent and had a steep threshold, only occurring above 108 M dopamine. The dopamine-mediated increase in entry required dopamine receptor activation, as it was abrogated by the pan-dopamine receptor antagonist flupenthixol, and could be mediated through both subtypes of dopamine receptors. These findings indicate that the effects of dopamine on macrophages may have a significant impact on HIV pathogenesis. They also suggest that drug-induced increases in CNS dopamine may be a common mechanism by which drugs of abuse with distinct modes of action exacerbate neuroinflammation and contribute to HIV-associated neurocognitive disorders in infected drug abusers. |
| first_indexed | 2024-12-10T10:47:43Z |
| format | Article |
| id | doaj.art-c21205dd64f34193987e3cafebc37caa |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-10T10:47:43Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-c21205dd64f34193987e3cafebc37caa2022-12-22T01:52:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10823210.1371/journal.pone.0108232Dopamine receptor activation increases HIV entry into primary human macrophages.Peter J GaskillHideaki H YanoGanjam V KalpanaJonathan A JavitchJoan W BermanMacrophages are the primary cell type infected with HIV in the central nervous system, and infection of these cells is a major component in the development of neuropathogenesis and HIV-associated neurocognitive disorders. Within the brains of drug abusers, macrophages are exposed to increased levels of dopamine, a neurotransmitter that mediates the addictive and reinforcing effects of drugs of abuse such as cocaine and methamphetamine. In this study we examined the effects of dopamine on HIV entry into primary human macrophages. Exposure to dopamine during infection increased the entry of R5 tropic HIV into macrophages, irrespective of the concentration of the viral inoculum. The entry pathway affected was CCR5 dependent, as antagonizing CCR5 with the small molecule inhibitor TAK779 completely blocked entry. The effect was dose-dependent and had a steep threshold, only occurring above 108 M dopamine. The dopamine-mediated increase in entry required dopamine receptor activation, as it was abrogated by the pan-dopamine receptor antagonist flupenthixol, and could be mediated through both subtypes of dopamine receptors. These findings indicate that the effects of dopamine on macrophages may have a significant impact on HIV pathogenesis. They also suggest that drug-induced increases in CNS dopamine may be a common mechanism by which drugs of abuse with distinct modes of action exacerbate neuroinflammation and contribute to HIV-associated neurocognitive disorders in infected drug abusers.http://europepmc.org/articles/PMC4182469?pdf=render |
| spellingShingle | Peter J Gaskill Hideaki H Yano Ganjam V Kalpana Jonathan A Javitch Joan W Berman Dopamine receptor activation increases HIV entry into primary human macrophages. PLoS ONE |
| title | Dopamine receptor activation increases HIV entry into primary human macrophages. |
| title_full | Dopamine receptor activation increases HIV entry into primary human macrophages. |
| title_fullStr | Dopamine receptor activation increases HIV entry into primary human macrophages. |
| title_full_unstemmed | Dopamine receptor activation increases HIV entry into primary human macrophages. |
| title_short | Dopamine receptor activation increases HIV entry into primary human macrophages. |
| title_sort | dopamine receptor activation increases hiv entry into primary human macrophages |
| url | http://europepmc.org/articles/PMC4182469?pdf=render |
| work_keys_str_mv | AT peterjgaskill dopaminereceptoractivationincreaseshiventryintoprimaryhumanmacrophages AT hideakihyano dopaminereceptoractivationincreaseshiventryintoprimaryhumanmacrophages AT ganjamvkalpana dopaminereceptoractivationincreaseshiventryintoprimaryhumanmacrophages AT jonathanajavitch dopaminereceptoractivationincreaseshiventryintoprimaryhumanmacrophages AT joanwberman dopaminereceptoractivationincreaseshiventryintoprimaryhumanmacrophages |